Cartesian Therapeutics Operating Cycle Over Time
| RNAC Stock | 7.55 0.06 0.79% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Cartesian Therapeutics Performance and Cartesian Therapeutics Correlation. Cartesian | Build AI portfolio with Cartesian Stock |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cartesian Therapeutics. If investors know Cartesian will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cartesian Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.07) | Earnings Share (1.33) | Revenue Per Share | Quarterly Revenue Growth 0.168 | Return On Assets |
The market value of Cartesian Therapeutics is measured differently than its book value, which is the value of Cartesian that is recorded on the company's balance sheet. Investors also form their own opinion of Cartesian Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Cartesian Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cartesian Therapeutics' market value can be influenced by many factors that don't directly affect Cartesian Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cartesian Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Cartesian Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cartesian Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Operating Cycle Analysis
Compare Cartesian Therapeutics and related stocks such as Eupraxia Pharmaceuticals, Inventiva Sa, and Nautilus Biotechnology Operating Cycle Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| IVA | 296 | 296 | 296 | 296 | 471 | 199 | 290 | 524 | 1.7 K | 33.5374 | 13.4 K | 1.1 K | 417 | (6.3 K) | 301 | 347 | 329 |
| NAUT | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| OBIO | 184 | 184 | 184 | 184 | 184 | 184 | 184 | 184 | 184 | 184 | 184 | 68.2466 | 323 | 300 | 322 | 290 | 192 |
| MDWD | 1.2 K | 1.2 K | 1.2 K | 3 K | 3 K | 2 K | 777 | 910 | 1.1 K | 96.9229 | 81.7712 | 62.8496 | 184 | 152 | 159 | 183 | 174 |
| AARD | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| FENC | 16.1 M | 2.9 K | 2.9 K | 2.9 K | 2.9 K | 2.9 K | 2.9 K | 2.9 K | 2.9 K | 2.9 K | 2.9 K | 2.9 K | 2.9 K | 776 | 220 | 254 | 241 |
| AVTX | 42.4234 | 42.4234 | 42.4234 | 42.4234 | 42.4234 | 42.4234 | 42.4234 | 258 | 175 | 270 | 243 | 334 | 40.9289 | 25.8004 | 506 | 455 | 478 |
| GNFT | 120 | 894 | 918 | 999 | 275 | 4.2 K | 10.8 K | 1.3 K | 2.1 K | 151 | 5.7 K | 42.0541 | 293 | 422 | 46.0723 | 41.47 | 39.39 |
Cartesian Therapeutics and related stocks such as Eupraxia Pharmaceuticals, Inventiva Sa, and Nautilus Biotechnology Operating Cycle description
My Equities
My Current Equities and Potential Positions
| Cartesian Therapeutics | RNAC |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Business Address | 7495 New Horizon |
| Exchange | NASDAQ Exchange |
null 7.55
Check out Cartesian Therapeutics Performance and Cartesian Therapeutics Correlation. For information on how to trade Cartesian Stock refer to our How to Trade Cartesian Stock guide.You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Cartesian Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.